What does this research mean for the field?

Thromboembolism, particularly migratory thrombophlebitis resistant to anticoagulant therapy, can serve as an early presenting sign of primary bronchogenic carcinoma and is associated with a poor prognosis. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

December 11, 1967JAMA

Bronchogenic Carcinoma and Thromboembolic Disease

View Full Paper

Ask AI

Bookmark

Population

37 patients with primary bronchogenic carcinoma who developed thromboembolism as an early complication…

Design

Case_series

Authors

RBRichard B. ByrdUniversity of Minnesota

Discussion

Member takes

Implication

Resistant migratory thrombophlebitis may signal occult lung cancer; case reports leave open its prevalence and utility today.

Structured PICO

Population

37 patients with primary bronchogenic carcinoma who developed thromboembolism as an early complication during a six-year period

Unexplained, migratory, and treatment-resistant thrombophlebitis can be an early clinical indicator of underlying bronchogenic carcinoma and portends a poor prognosis.

Limitations

Uncertainties of retrospective diagnosis
Uncertainties of follow-up

Cite This Study

Richard B. Byrd (1967) studied this question.

synapsesocial.com/papers/6a1b5f0bdb618aee6aabcf44 https://doi.org/10.1001/jama.1967.03130240061011

View Full Paper

Ask AI

Bookmark

Bronchogenic Carcinoma and Thromboembolic Disease

Discussion

Member takes

Implication

Structured PICO

Limitations

Cite This Study

Bronchogenic Carcinoma and Thromboembolic Disease

Discussion

Member takes

Implication

Structured PICO

Limitations

Cite This Study

Also Consider

Also Consider